10 drugs to watch
March 25, 2014 2:18 PM
Cymbalta
Used for: Depression
Manufactured by: Lilly
Estimated annual sales: $4.7 billion
Generic: duloxetine
Generic launch date: December 2013
Images: Shutterstock
Lidoderm 5%
Used for: Skin conditions
Manufactured by: Endo
Estimated annual sales: $1.3 billion
Generic: lidocaine topical patch
Generic launch date: September 2013
Niaspan
Used for: High blood cholesterol
Manufactured by: AbbVie
Estimated annual sales: $1.2 billion
Generic: niacin, extended release
Generic launch date: September 2013
AcipHex
Used for: Ulcer disease
Manufactured by: Eisai
Estimated annual sales: $901 million
Generic: rabeprazole
Generic launch date: November 2013
Suboxone Sublingual Tablets
Used for: Pain
Manufactured by: Reckitt Benkiser
Estimated annual sales: $697 million
Generic: buprenorphine/naloxone
Generic launch date: February 2013
Nexium
Used for: Ulcer disease
Manufactured by: AstraZeneca
Estimated annual sales: $6.1 billion
Generic: esomeprazole
Generic launch date: May 2014
Copaxone 20 mg/mL
Used for: Mental/neurological disorders
Manufactured by: Teva
Estimated annual sales: $3.7 billion
Generic: glatiramer acetate
Generic launch date: May 2014
Diovan
Used for: High blood pressure/heart disease
Manufactured by: Novartis
Estimated annual sales $2.1 billion
Generic: valsartan
Generic launch date: Mid-2014
Renvela
Used for: Gastrointestinal disorders
Manufactured by: Genzyme
Estimated annual sales: $889 million
Generic: sevelamer carbonate
Generic launch date: March 2014
Lunesta
Used for: Sleep disorders
Manufactured by: Sunovion
Estimated annual sales: $852 million
Generic: eszopiclone
Generic launch date: April 2014
